107 related articles for article (PubMed ID: 7471607)
1. Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.
Wang LH; Lee CS; Majeske BL; Marbury TC
Clin Pharmacol Ther; 1981 Mar; 29(3):365-72. PubMed ID: 7471607
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of primidone elimination by uremic patients.
Lee CS; Marbury TC; Perchalski RT; Wilder BJ
J Clin Pharmacol; 1982 Jul; 22(7):301-8. PubMed ID: 7107978
[TBL] [Abstract][Full Text] [Related]
3. Clearance calculations in hemodialysis: application to blood, plasma, and dialysate measurements for ethambutol.
Lee CS; Marbury TC; Benet LZ
J Pharmacokinet Biopharm; 1980 Feb; 8(1):69-81. PubMed ID: 7381692
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of dyphylline elimination by uremic patients.
Lee CC; Wang LH; Majeske BL; Marbury TC
J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis of acetaminophen in uremic patients.
Marbury TC; Wang LH; Lee CS
Int J Artif Organs; 1980 Sep; 3(5):263-6. PubMed ID: 7461859
[TBL] [Abstract][Full Text] [Related]
6. Hemodialysis clearance and total body elimination of carbamazepine during chronic hemodialysis.
Lee CS; Wang LH; Marbury TC; Bruni J; Perchalski RJ
Clin Toxicol; 1980 Oct; 17(3):429-38. PubMed ID: 7449356
[TBL] [Abstract][Full Text] [Related]
7. Hemodialysis clearance of ethosuximide in patients with chronic renal disease.
Marbury TC; Lee CS; Perchalski RJ; Wilder BJ
Am J Hosp Pharm; 1981 Nov; 38(11):1757-60. PubMed ID: 7304633
[TBL] [Abstract][Full Text] [Related]
8. Hemodialysis of mefenamic acid in uremic patients.
Wang LH; Lee CS; Marbury TC
Am J Hosp Pharm; 1980 Jul; 37(7):956-8. PubMed ID: 7395889
[TBL] [Abstract][Full Text] [Related]
9. Elimination characteristics of bredinin from patients serum in hemodialysis.
Takada K; Yoshikawa H; Muranishi S; Takahara S; Nagano S; Fukunishi T; Sonoda T; Ichikawa Y
Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):197-9. PubMed ID: 3997305
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis clearance of chloroquine in uremic patients.
Akintonwa A; Odutola TA; Edeki T; Mabadeje AF
Ther Drug Monit; 1986; 8(3):285-7. PubMed ID: 3750371
[TBL] [Abstract][Full Text] [Related]
11. Radionuclide method for evaluating the performance of hemodialysis in vivo.
Bihl GR; Bird NJ; Peters C; Bradley JR; Peters AM
Kidney Int; 2005 Feb; 67(2):721-31. PubMed ID: 15673322
[TBL] [Abstract][Full Text] [Related]
12. Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.
Gwilt PR; Perrier D
Clin Pharmacol Ther; 1978 Aug; 24(2):154-61. PubMed ID: 679594
[TBL] [Abstract][Full Text] [Related]
13. The influence of hemodialysis on the pharmacokinetics of ibuprofen and its major metabolites.
Antal EJ; Wright CE; Brown BL; Albert KS; Aman LC; Levin NW
J Clin Pharmacol; 1986 Mar; 26(3):184-90. PubMed ID: 3958223
[TBL] [Abstract][Full Text] [Related]
14. Removal of phenytoin by hemodialysis in uremic patients.
Martin E; Gambertoglio JG; Adler DS; Tozer TN; Roman LA; Grausz H
JAMA; 1977 Oct; 238(16):1750-3. PubMed ID: 578272
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis clearance of total and unbound lidocaine.
Jacobi J; McGory RW; McCoy H; Matzke GR
Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
[TBL] [Abstract][Full Text] [Related]
16. Clearance of gentamicin during hemodialysis: comparison of four artificial kidneys.
Halpren BA; Axline SG; Coplon NS; Brown DM
J Infect Dis; 1976 Jun; 133(6):627-36. PubMed ID: 932490
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of felodipine in chronic hemodialysis patients.
Buur T; Larsson R; Regårdh CG; Aberg J
J Clin Pharmacol; 1991 Aug; 31(8):709-13. PubMed ID: 1880229
[TBL] [Abstract][Full Text] [Related]
18. Metronidazole kinetics in dialysis patients.
Kreeft JH; Ogilvie RI; Dufresne LR
Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of oritavancin clearance from human blood by low-flux, high-flux, and continuous renal replacement therapy dialyzers.
Kumar A; Mann HJ; Keshtgarpour M; Flynn MA; Deng H; Far AR; Parr TR; Moriarty SR
Int J Artif Organs; 2011 Nov; 34(11):1067-74. PubMed ID: 22183520
[TBL] [Abstract][Full Text] [Related]
20. The effect of hemodialysis on cycloserine, ethionamide, para-aminosalicylate, and clofazimine.
Malone RS; Fish DN; Spiegel DM; Childs JM; Peloquin CA
Chest; 1999 Oct; 116(4):984-90. PubMed ID: 10531163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
